Your browser doesn't support javascript.
loading
Impact of initial therapy with upadacitinib or adalimumab on achievement of 48-week treatment goals in patients with rheumatoid arthritis: post hoc analysis of SELECT-COMPARE.
Mysler, Eduardo; Tanaka, Yoshiya; Kavanaugh, Arthur; Aletaha, Daniel; Taylor, Peter C; Song, In-Ho; Shaw, Tim; Song, Yanna; DeMasi, Ryan; Ali, Mira; Fleischmann, Roy.
Afiliación
  • Mysler E; Organización Medica de Investigación, Buenos Aires, Argentina.
  • Tanaka Y; The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
  • Kavanaugh A; Division of Rheumatology, Allergy, & Immunology, University of California San Diego Medical School, San Diego, CA, USA.
  • Aletaha D; Division of Rheumatology, Department of Medicine, Medical University of Vienna, Vienna, Austria.
  • Taylor PC; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
  • Song IH; AbbVie, North Chicago, IL, USA.
  • Shaw T; AbbVie Ltd, Maidenhead, UK.
  • Song Y; AbbVie, North Chicago, IL, USA.
  • DeMasi R; AbbVie, North Chicago, IL, USA.
  • Ali M; AbbVie, North Chicago, IL, USA.
  • Fleischmann R; Department of Medicine, University of Texas Southwestern Medical Center, Metroplex Clinical Research Center, Dallas, TX, USA.
Rheumatology (Oxford) ; 62(5): 1804-1813, 2023 05 02.
Article en En | MEDLINE | ID: mdl-36018230

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Antirreumáticos Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Argentina

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Antirreumáticos Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Argentina